1. Coley WB. The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med. 1910;3(Surg Sect):1–48.
2. Foley EJ. Antigenic properties of Methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953;13:835.
3. Prehn RT, Main JM. Immunity to Methylcholanthrene-induced sarcomas. J Nat Cancer Inst. 1957;18:769.
4. Morton DL, Malmgren RA, Holmes EC, Ketcham AS. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968;64:233.
5. Ramirez-Montagut T, Turk MJ, Wolchok JD, Guevara-Patino JA, Houghton A. Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity. Oncogene. 2003;22:3180–7.